Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study

BACKGROUND: Patients with COVID-19 who develop severe acute respiratory distress syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and death. The efficacy of extracorporeal membrane oxygenation (ECMO) for patients with severe ARDS in the context of COVID-19 is unclear. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Matthieu, Hajage, David, Lebreton, Guillaume, Monsel, Antoine, Voiriot, Guillaume, Levy, David, Baron, Elodie, Beurton, Alexandra, Chommeloux, Juliette, Meng, Paris, Nemlaghi, Safaa, Bay, Pierre, Leprince, Pascal, Demoule, Alexandre, Guidet, Bertrand, Constantin, Jean Michel, Fartoukh, Muriel, Dres, Martin, Combes, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426089/
https://www.ncbi.nlm.nih.gov/pubmed/32798468
http://dx.doi.org/10.1016/S2213-2600(20)30328-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426089/
https://www.ncbi.nlm.nih.gov/pubmed/32798468
http://dx.doi.org/10.1016/S2213-2600(20)30328-3

Ejemplares similares